Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3028% below fair value

$3.31+0.24 (+7.82%)

Close on Nov 12, 2026Market cap $35.95MP/E 18.4Yield –

Nephros EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Nephros's EV/EBITDA was 16.2× on Nov 11, 2026, against 29.4× a year earlier.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	16.2×	−13.2
2025	Dec 31, 2025	29.4×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is NEPH.

Revenue growth20.4% · median 18.4%

Gross margin60.5% · median 60.8%

Operating margin8.5% · median -2.3%

Net margin8.9% · median -7.6%

Advertisement
300 × 250

See a number that looks wrong?